Titomic Ltd
0.11
AUD
-0.02
(-15.38%)
Titomic Ltd
ASX:TTT
(Australian Securities Exchange)
Recent
price
0.11
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- Titomic Limited specializes in industrial-scale metal additive manufacturing and cold spray coating technology using its patented Titomic Kinetic Fusion (TKF) process. The company manufactures advanced metal parts and components through cold spray additive manufacturing, allowing it to create large, multi-metal, high-performance components and complex surface coatings without melting materials. Titomic’s product offerings include the TKF1000 modular additive manufacturing system for prototyping, R&D, small-run production, and on-demand manufacturing; cold spray systems such as D523 and D623 for faster, stronger metal coatings and repairs; and the ISB-L Integrated Spray Booth system that optimizes process control and efficiency. The company serves diverse sectors including aerospace, defense, automotive, mining, oil and gas, shipbuilding, and energy, targeting customers requiring corrosion-resistant, heat-resistant, and electrically conductive coatings and repairs. Headquartered in Melbourne, Australia, Titomic also provides OEM production, R&D services, metal powder supply, and global sales support from its Australian base. In the last 1-2 years, Titomic has undergone significant strategic expansion and operational growth. It successfully transitioned from a capital equipment sales model to a high-margin “cold spray as a service” and leasing business model, driving a 37% revenue growth in FY2025. The company raised AUD 80 million in capital, fueling its global expansion, notably establishing a 59,000 square foot global headquarters and manufacturing facility in Huntsville, Alabama, strategically located near major U.S. defense and aerospace contractors. This expansion supports growing Tier 1 government contracts with organizations such as NAVSEA, Northrop Grumman, and Airbus MRO. Titomic also secured supply agreements with U.S.-based titanium and refractory metal powder suppliers to stabilize its supply chain, alongside ongoing funding from U.S. government grants and Australian national funds. The Netherlands facility is undergoing capacity expansion to meet increasing demand as the company deepens its footprint in the U.S., Europe, and Asia-Pacific markets with plans to further penetrate China and India. Recent developments include new sales to key customers OMIC R&D and Triton Systems and a shift to align financial reporting with U.S. and European operations, emphasizing recurring revenue streams and vertical integration. Overall, Titomic Limited operates as a leading innovator in metal additive manufacturing with its proprietary cold spray technology, delivering metal parts, coatings, and repair solutions with applications across critical global industries. It continues to grow its manufacturing capabilities and market presence internationally while capitalizing on expanded U.S. defense contracts and global strategic partnerships. Founded in 2014 and headquartered in Melbourne, Australia, Titomic positions itself as a future-focused global player targeting substantial revenue growth through technology commercialization and geographic diversification. The company maintains multiple revenue streams including system sales, metal powder, bureau services, and leasing programs, positioning it for sustained expansion within industrial additive manufacturing markets worldwide.
Company News
Titomic Limited (TITMF) Shareholder/Analyst Call Transcript
Titomic awarded US$5.0 million U.S. defense contract for next-generation cold spray system
Titomic USA, Inc. Celebrates One Year of Operations, Marking Significant Growth and Expansion in Advanced Manufacturing
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI
Titomic lands $1.7 million Royal NLR order for cold spray systems
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback
Microsoft price target lowered on M365, Copilot questions
Atlassian to reduce headcount by 10% as it restructures around AI
Titomic plans US redomicile as defence market focus grows
Tap Global shares rise 6% as directors lock in 63% of shares for three years
Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
Titomic Limited (TITMF) Shareholder/Analyst Call Transcript